The main theorem of the present paper is the bistability theorem for a four dimensional cancer model, in the variables M C C GF GI , , , representing primary cancer C, metastatic cancer M C , growth factor GF and growth inhibitor GI, respectively. It says that for some values of the parameters this system is bistable, in the sense that there are exactly two positive singular points of this vector field. And one is stable and the other unstable. We also find an expression for ( ) 
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Summary of the Paper
We continue the study of the cancer model from Larsen (2016) [1] . The model is ∈  . We have shown previously Larsen (2016) [1] , that there are affine vector fields on 3  , such that their time one map is T, when the eigenvalues of A have positive real part. This enables you to find a formula for the rate of change of cancer growth in 0 C = . The characteristic polynomial of A is ( ) T . This enables us to find a formula for the rate of change of cancer growth in 0. C = This is the subject of Section 3.
The phase space of our model T is 3 +  . In section four we show, that when 0
> orbits of the vector field associated to T will escape phase space for both 0 t > and 0 t < . We obtain a formula for the first escape time. There is a similar treatment for 0. ∇ >
The Litterature
uPAR (urokinase plasminogen activator receptor) is a cell surface protein, that is associated with invasion and metastasis of cancer cells. In Liu et al. (2014) [2] a cytoplasmic protein Sprouty1 (SPRY1) an inhibitor of the (Ras-mitogen activated protein kinase) MAPK pathway is shown to interact with uPAR and cause it to be degraded. Overexpression of SPRY1 in HCT116 or A549 xenograft in athymic nude mice, led to great suppression of tumor growth. SPRY1 is an inhibitor of the MAPK pathway. Several cancer cells have a low basal expression of SPRY1, e.g. breast, prostate and liver cancer. SPRY1 promotes the lysosomal mediated degradation of uPAR. SPRY1 overexpression results in a decreased expression of uPAR protein. This paper suggests that SPRY1 regulates cell adhesion through an uPAR dependant mechanism. SPRY1 inhibits proliferation via two distinct pathways: 1) SPRY1 is an intrinsic inhibitor of the Raf/MEK/ERK pathway; 2) SPRY1 promotes degradation of uPAR, which leads to inhibition of FAK and ERK activation.
According to Luo and Fu (2014) , [3] EGFR (endoplasmic growth factor receptor) tyrosine kinase inhibitors (TKIs) are very efficient against tumors with EGFR activating mutations in the EGFR intracytoplasmic tyrosin kinase domain and cell apoptosis was the result. However some patients developed resistance and this reference aimed to elucidate molecular events involved in the resistance to EGFR-TKIs. The first EGFR-TKI s to be approved by the FDA (Food and Drug Administration, USA) for treatment of NSCLC (non small cell lung cancer) were gefitinib and erlotinib. The mode of action is known. These drugs bind to the ATP binding site of EGFR preventing autophosphorylation and then blocking downstream signalling cascades of pathways RAS/ RAF/MEK/ERK and PI3K/AKT with the results, proliferation inhibition, cell cycle progression delay and cell apoptosis.
There are several important monographs relevant to the present paper, see Adam & Bellomo (1997) , [4] , Geha & Notarangelo (2012), [5] , Murphy (2012) , [6] , Marks (2009) , [7] , Molina (2011), [8] .
A mass Action Kinetic Model of Metastatic Cancer
The main result of this section is Theorem 1 below that proves the bistability of the mass action kinetic system (1) to (8) . Consider then the mass action kinetic system from Larsen (2016), [9] , in the species , , , M C C GF GI primary cancer cells, metastatic cancer cells, growth factor, growth inhibitor respectively.
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We shall now find the singular points of this vector field denoted 4 4 :
But first we state a theorem, we shall next prove. A positive (nonnegative) singular point ( ) Define   15  15  1  21  2  31  21  31  51  21  31  51 , 0  95  95 1  1  2  2  59  59 , , , , 
Setting the last coordinate of f equal to zero gives 95 * 54 * 56 * 59 
and 
and from (10) 
In Larsen (2016) [9] , we found two cubic polynomials , M P P such that , . , , .
C is according to Larsen (2016) , [9] ( ) ( 
Everything cancels out and leaves a zero. The coefficient to 2 M C is according to Larsen (2016) , [9] ( ) ( 
The coefficient to M C is according to Larsen (2016) , [9] ( )( (15) and (16) 
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are not singular points of f. Here , 95 * 54 * 56 * 59
We have ( )
and logically equivalent ( )
where ( ) 
and from this the formula follows. And (16) is a similar computation.
We shall insert (15) , (16) 
Now abbreviate x k = ± ∇ and find
and this vanishes due to the formula for roots of quadratic polynomials. That the second coordinate vanishes is logically equivalent. So (11) 
But (17) is zero by the above and (18) 
We shall now verify that ( ) 
Simply insert (15) and (16) 
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is stable for small 59 k . This follows by writing ( )
and h is smooth. This is the standard trick from singularity theory. Then 
And from this it follows that ( ) Consider the mass action kinetic system in the species , , , C GF GI P cancer cells, growth factor, growth inhibitor and a protein, respectively.
GF C
see Horn and Jackson (1972) , [10] . Notice that (24), (25) are the Brusselator, which is known to have oscillating solutions for some values of the parameters, see Sarmah et al. (2015) , [11] . Subtracting 2C on both sides of (25) gives the reaction . P C → 
Eigenvalues with Negative Real Part
In this section 0, 0 
If λ + has negative real part we might be able to find an affine vector field whose time one map is 2  1  2  3  2  3  2  3  1  1 , , ,
. 
sin tan 1 GF GI ∈  And, because ( ) 
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The second coordinate here should be equal to ( ) 
Escaping Phase Space
In this section 0, 0. 
We have the following formula ( ) 
We shall now derive a formula for the first escape time . FET + ∈  To start with, assume that 3 , c 
e cos sin 
By 
Summary and Discussion
In this paper we proved that the model of primary and metastatic cancer in Section 2 is bistable, in the sense, that there are exactly two positive singular points. One of them is unstable, and when one of the rate constants is small the other is stable. Then we found formulas for the rate of change of cancer growth for the model T of the introduction, when for 0 ∇ > the eigenvalues , λ λ + − are nonzero and for 0 ∇ < when 2 2 0. a b − > In section four we proved that there is a first escape time for the flow of the affine vector field associated to T when 0.
∇ <
A similar result when 0 ∇ > was also treated.
It would be interesting to figure out what happens if the polynomials , M P P of section 2 are cubic polynomials and not quadratic as in Theorem 1.
About the References
How do cancer cells coordinate glycolysis and biosynthesis. They do that with the aid of an enzyme called Phosphoglycerate Mutase 1. In the reference [12] , the authors suggest a dynamical system for their findings in a figure at the end of the paper. In the reference [13] , A. K. Laird showed that solid tumors do not grow exponentially, but rather like a Gompertz function. The publications of the author are concerned with semi Riemannian dynamical systems, e.g. Lorentzian Geodesic Flows, see [14] and electrical network theory of countable graphs, see [15] , [16] .
